CURE

Calendar of CURE/Yale BioHaven seminars for Fall 2010 now available. more

9/14
8:45 am - 6:00 pm
Ubifrance, the French Agency for international business development, cordially invites CURE members to this year's second French Biotech Tour, which aims to connect French and American Biotech companies specialized in neuroscience, inflammation, and auto-immune diseases. Philadelphia, PA. more

9/16
6:00 pm - 7:30 pm
CURE/Yale BioHaven presents Al Mann: 'Creating a successful medical device enterprise.' Hope Auditorium, Yale University, 315 Cedar Street, New Haven. more

10/5
Deadline for nominations for the Lemelson-MIT prize, awarded to an outstanding mid-career inventor who has developed a patented product or process of significant value to society. more

10/27
4:00 pm - 6:00 pm
CURE/Yale BioHaven presents Cobalt Therapeutics. Anlyan Center, Yale University, 300 Cedar Street, New Haven. more

11/18
4:00 pm - 6:00 pm
CURE/Yale BioHaven presents Biodel Inc. Anlyan Center, Yale University, 300 Cedar Street, New Haven. more

12/7
5:30 pm - 7:30 pm
CURE Holiday Party. Café George, 300 George Street, New Haven. Watch for details.

CuraGen Corporation
322 East Main Street
Branford, CT 06405

Phone: 203-481-1104
Fax: 203-483-2552
Website: http://www.curagen.com

Contact(s)
Glenn Schulman - gschulman@curagen.com

General Information
CuraGen Corporation (Nasdaq: CRGN) is a clinical-stage biopharmaceutical company developing promising approaches for the treatment of cancer. CuraGen Corporation is headquartered in Branford, Connecticut.

Research Activities
CuraGen is focused on developing therapeutics for the treatment of cancer. CR011-vcMMAE, , an antibody-drug conjugate, targets GPNMB, a novel therapeutic target overexpressed by melanoma, breast cancer and gliomas. CuraGen is currently evaluating CR011-vcMMAE currently in Phase II clinical development.

Other Information
Ownership: Public
Stock Symbol: CRGN
CT Employees: 25
World Employees: 25